Su Y Kim

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. pmc Dilemmas associated with congenital ewing sarcoma family tumors
    Su Young Kim
    Department of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
    J Pediatr Hematol Oncol 30:4-7. 2008
  2. pmc The role of IGF-1R in pediatric malignancies
    Su Young Kim
    Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA
    Oncologist 14:83-91. 2009
  3. doi Targeting IGF-1R in the treatment of sarcomas: past, present and future
    Su Young Kim
    Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
    Bull Cancer 96:E52-60. 2009
  4. pmc Pediatric and wild-type gastrointestinal stromal tumor: new therapeutic approaches
    Su Y Kim
    Pediatric Oncology Branch National Cancer Institute National Institutes of Health, Bethesda, Maryland 20892, USA
    Curr Opin Oncol 22:347-50. 2010
  5. doi Stratifying osteosarcoma: minimizing and maximizing therapy
    Lisa M Niswander
    Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, 10 Center Drive, Bethesda, MD 20892, USA
    Curr Oncol Rep 12:266-70. 2010
  6. ncbi Detection of chromosome-specific aneusomy and translocation by benzene metabolites in human lymphocytes using fluorescence in situ hybridization with DNA probes for chromosomes 5, 7, 8, and 21
    Hai Won Chung
    School of Public Health, Seoul National University, Korea
    J Toxicol Environ Health A 65:365-72. 2002

Collaborators

Detail Information

Publications6

  1. pmc Dilemmas associated with congenital ewing sarcoma family tumors
    Su Young Kim
    Department of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
    J Pediatr Hematol Oncol 30:4-7. 2008
  2. pmc The role of IGF-1R in pediatric malignancies
    Su Young Kim
    Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA
    Oncologist 14:83-91. 2009
    ..These findings have led to the development of a host of IGF-1R signaling modulators that are currently being tested in clinical trials. This review explores the role of IGF-1R in a range of childhood malignancies...
  3. doi Targeting IGF-1R in the treatment of sarcomas: past, present and future
    Su Young Kim
    Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
    Bull Cancer 96:E52-60. 2009
    ..In this review, we will focus on preclinical highlights in the past, current clinic trials and discuss some exciting research opportunities to foster advances in the future...
  4. pmc Pediatric and wild-type gastrointestinal stromal tumor: new therapeutic approaches
    Su Y Kim
    Pediatric Oncology Branch National Cancer Institute National Institutes of Health, Bethesda, Maryland 20892, USA
    Curr Opin Oncol 22:347-50. 2010
    ..In this review, we will discuss the differences between children and adults with gastrointestinal stromal tumor and some new potential therapeutic agents...
  5. doi Stratifying osteosarcoma: minimizing and maximizing therapy
    Lisa M Niswander
    Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, 10 Center Drive, Bethesda, MD 20892, USA
    Curr Oncol Rep 12:266-70. 2010
    ..We then focus on two molecular targets for the treatment of patients with high-risk osteosarcoma...
  6. ncbi Detection of chromosome-specific aneusomy and translocation by benzene metabolites in human lymphocytes using fluorescence in situ hybridization with DNA probes for chromosomes 5, 7, 8, and 21
    Hai Won Chung
    School of Public Health, Seoul National University, Korea
    J Toxicol Environ Health A 65:365-72. 2002
    ....